The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.
Leaders Of 7 Pharmaceutical Manufacturers Face Tough Questioning On Capitol Hill
The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.